Source: CDC
Topic: CDC identifies four urgent antimicrobial resistance threats
The CDC’s 2026 antimicrobial resistance report identifies 19 drug-resistant pathogens responsible for an estimated 9.7 million infections and 50,800 deaths annually in the United States. Four are classified as urgent threats: Candida auris, carbapenem-resistant Acinetobacter, carbapenem-resistant Enterobacterales (CRE), and drug-resistant Neisseria gonorrhoeae.
Several findings deserve particular attention:
Gonorrhea: Reduced ceftriaxone susceptibility remained rare (0.1% of isolates in 2023), but resistance or reduced susceptibility to at least one monitored antibiotic increased to 55.4%.
C. auris: Clinical cases have increased nearly tenfold since 2019, with emerging echinocandin resistance.
CRE: New Delhi metallo-β-lactamase (NDM)-producing infections increased nearly fivefold between 2019 and 2023.
Pertussis: Macrolide-resistant cases remain rare, with only two identified in 2024–2025.
Link: https://arthreats.cdc.gov/
@HakimApps_Guideline